Business Development Executive Joins Clarion Team
January, 2012 — Elizabeth Sheehan, MBA, has joined Clarion’s consulting team, bringing extensive experience in the healthcare and financial services industries, a deep understanding of market research, and a track record of providing client solutions. As a former Vice President at Gerson Lehrman Group, one of the largest global primary research firms, Liz managed hedge fund, private equity and venture capital clients both in the Healthcare Research Group and in Private Equity and Venture Capital Account Management. Working closely with clients to understand and address their needs, Liz created highly customized market research solutions – including in-person meetings, written surveys, and phone consultations to enhance deal sourcing, due diligence and portfolio management.
“Liz’s knowledge of the healthcare and financial services industries combined with her intimate understanding of market research and 10 years of client management experience make her a terrific addition to the Clarion team,” said Gordon Walton, Clarion Managing Director and head of the Technology, Opportunity and Asset Evaluation practice. “We welcome her contributions to our growing relationships with private equity and venture capital investors and to our support of pharmaceutical and biotech business development and licensing activities.
Liz received her MBA from the Darden Graduate School of Business at the University of Virginia and her BA from Cornell University.
Clarion Announces Launch of Speaker Series
November 7, 2011 – Clarion is pleased to announce the launch of the “Clarion Speaker Series.” The Speaker Series brings outside experts into Clarion on an ongoing basis to share their perspectives and stimulate discussion and thinking on issues that are critical to Clarion, its clients, and the healthcare industry. Speakers include CEOs, drug development experts, nationally recognized physicians, health quality improvement strategists, regulation and reimbursement experts, and others. Clarion launched the program on November 4th, with Jason Rhodes, EVP and Chief Business officer of Epizyme. Mr. Rhodes spoke about personalized medicine and its impact on drug development.
For more information about Epizyme, click here.
Clarion Joins NHIA
October 21, 2011 – Clarion has become a silver member of the National Home Infusion Association (NHIA), an association representing and advancing the interests of organizations that provide infusion and specialized pharmacy products and services to the spectrum of home-based patients.
“Alternative site care continues to be a rapidly evolving and important option for improving patient care and efficiencies across the healthcare system,” said Tom Murtagh, a Managing Director with Clarion. “Home infusion services are a growing part of this solution. Given Clarion’s extensive work in the field of oncology, we are eager to support the NHIA mission.”
Clarion remains committed to exploring leading edge delivery and patient care models to support its clients’ commitment to excellence in oncology patient care. For more information about the NHIA, click here.
Managing Director Co-Chairs PheoPara Alliance Gala
October 6, 2011 – Bart Lombardi served for the second consecutive year as co-chair of the PheoPara Alliance Gala. The gala supports the mission of the PheoPara Alliance, an organization dedicated to the diagnosis, treatment and cure of Pheochromocytoma and Paraganglioma, rare adrenal gland-based tumors. “Adrenal gland-based tumors can be devastating to patients and families, but with education and early diagnosis there are increasingly good options to treat — and hopefully one day to cure — these diseases,” said Lombardi. “We at Clarion are proud to join the PheoPara Alliance in supporting this worthwhile and important cause.”
For more information about the PheoPara Alliance and how to support this cause, click here.
Consultant Named to Board of Hemophilia Organization
October, 2011 – Bonnie Perkins, a Consultant with Clarion, was appointed to the Board of Directors of Save One Life (SOL), an international nonprofit organization providing sponsorship funds to people with hemophilia in developing countries. SOL also offers program support to groups to promote long term care and NGO recognition. Working in over 10 countries, SOL receives support from individuals, groups and corporations.
Bonnie brings a wealth of relevant experience to the organization, having worked in the hemophilia commercial group at Biogen Idec before joining Clarion. Bonnie will help the SOL development program to reach its strategic goals, including attaining 2,500 sponsorships in 2015.
For more information about the Save One Life, click here.